4th Winter Conference on
Medicinal and Bioorganic Chemistry (WCMBC)
January 28-February 2,
2001
Sheraton Conference Center, Steamboat Springs, Colorado
Conference Program
Sunday
| Monday | Tuesday | Wednesday
| Thursday | Friday
Sunday, January 28, 2001
Welcome Reception and Super
Bowl Party
4:00 pm-7:00 pm
Grand Ballroom
Symposia Topic 1: Modern
Heterocyclic Construction
Victor Snieckus, Queen’s University, Chair
7:00 pm
Speakers: Part I
Amir Hoveyda, Boston College
"Catalytic Enantioselective and Practical Olefin Metathesis
Reactions"
Jin K. Cha, University of Alabama
"New Synthetic Methods for Bioactive Heterocycles"
P. Andrew Evans, University of Delaware
"New Organometalice Mediated Cross-Coupling Reactions for the
Construction of Complex Biologically Important Natural Products."
Return to top
Monday, January 29, 2001
Continental Breakfast
7:30 am
Ballroom Foyer
Symposia Topic 1: Modern
Heterocyclic Construction
Victor Snieckus, Queen’s University, Chair
8:00 am – 11:00 am
Mt. Werner/Sunshine Peak
Speakers: Part II
Ron Grigg, University of Leeds
"Catalytic Cascade Reactions: Routes to Potentially Bio-active
Complex Heterocycles"
David J. Hart, Ohio State University
"New Wrinkles on Old Reactions in Heterocyclic Chemistry:
Applications to Alkaloid Total Synthesis"
Victor Snieckus, Queen’s University
"Constructing Substituted Heterocycles: Comparing Directed ortho
Metalation with Other Selected Methodologies"
Al Padwa, Emory University
"Cascade Processes for Heterocyclic Synthesis"
Poster Session 1
4:00pm – 5:00 pm
Storm Peak
Symposia Topic 2: Target-Driven
Approaches to Anticancer Agents
Bryan H. Norman, Eli Lilly and Company, Chair
5:00pm – 8:00 pm
Mt. Werner/Sunshine Peak
Speakers:
Homer Pearce, Eli Lilly and Company
"Evolving Molecular Targets for Anticancer Drug Discovery"
Peter L. Toogood, Pfizer Global R&D
"Inhibition of Cyclin Dependent Kinases as an Approach to Cancer
Therapy"
Louis Lombardo, Bristol-Myers Squibb
"The Discovery & Preclinical Development of Benzodiazepine
Farnsey Itransferase Inhibitors"
Peter Traxler, Novartis Pharma. Ltd.
"Tyrosine kinase inhibitors-from rational design to clinical
trials"
Return to top
Tuesday, January 30, 2001
Continental Breakfast
7:30 am
Ballroom Foyer
Symposia Topic 3: Pharmacokinetics
for Medicinal Chemists
David Lau, Amgen Inc., Chair
8:00 am – 11:00 am
Mt. Werner/Sunshine Peak
Speakers:
David Lau, Amgen Inc.
"Basic Pharmacokinetics Concepts for Medicinal Chemists in Drug
Discovery Support"
Gondi Kumar, Amgen Inc.
"Metabolism Issues for Small Molecule Drug Discovery and
Development"
2:00 pm – 3:30 pm
Hockey game at Howelson Arena
Symposia Topic 4: Recent Advances
in the Structural Biology of Seven Transmembrane Receptors
Daniel Flynn, Millennium Pharmaceuticals, Inc., Chair
5:00 pm – 7:30 pm
Mt. Werner/Sunshine Peak
Speakers:
Thue Schwartz, University of Copenhagen
"State of the 7TMG-protein union – lessons from metal-ion site
engineering and fusion proteins"
Dale Mierke, Brown University
"Peptide Hormone Binding to GPCR Receptors: Structural
Characterization via NMR Techniques"
Oren Becker, Bio Information Technologies
"Modeling the 3D Structure of G-Protein Coupled Receptors from
Primary Sequence"
Return to top
Wednesday, January 31, 2001
Continental
Breakfast
7:30 am
Ballroom Foyer
General Papers
Mike VanNieuwenhze, Chair
8:00 am – 11:00 am
Mt. Werner/Sunshine Peak
11:30 am Mountain Lunch at Buddy’s
Run, followed by group photo
2:00 pm NASTAR Race - NASTAR Race
Course
Keynote Address
5:30 pm
Grand Ballroom
Dale Boger, Scripps Research Institute
"Vancomycin, Teicoplanin, and Ramoplanin: Synthetic & Mechanistic
Studies"
Banquet
6:30 pm
Grand Ballroom
Dance
8:00 pm
Grand Ballroom
Return to top
Thursday, February 1, 2001
Continental Breakfast
7:30 am
Ballroom Foyer
Symposia Topic 5: Nuclear
Hormone Receptors
Lawrence G. Hamann, Bristol-Myers Squibb, Chair
Speakers: Part I
A Brian Jones, Merck Research Laboratories
"New PPAR Modulators: Diabetes and Beyond"
Marcus F. Boehm, Ligand Pharm., Inc.
"Rexinoid Receptor Signalling Pathways as Targets for Drug
Development"
Timothy M. Willson, Glaxo-Wellcome R&D
"Metabolic Regulation through Orphan Nuclear Receptors"
Poster Sessions 2
4:00 pm – 5:00 pm
Storm Peak
Symposia Topic 5: Nuclear
Hormone Receptors
Lawrence G. Hamann, Bristol-Myers Squibb, Chair
5:00 pm – 7:30 pm
Mt. Werner and Sunshine Peak
Speakers: Part II
Jean-Marie Wurtz, IGBMC
"Ligand Specificity in RXR, RAR and VDR"
John A. Katzenellenbogen, University of Illinois
"Novel Ligands for Estrogen Receptor Alpha and Beta"
Donald P. McDonnell, Duke Univ. Medical Center
"Nuclear Receptor-Cofactor Interactions as Targets for New Drug
Discovery"
Return to top
Friday, February 2, 2001
Continental
Breakfast
7:30 am
Ballroom Foyer
Symposia Topic 6: Alkene
Metathesis
Anthony G. M. Barrett, Imperial College, Chair
8:00 am – 12:00 noon
Mt. Werner/Sunshine Peak
Speakers:
Siegfried Blechert, Technische Universitat Berlin
"Sequential Olefin Metathesis—Applications in Natural Product
Synthesis"
Anthony G.M. Barrett, Imperial College
"Alkene Metathesis: Applications from Small Moleculels to
ROMPGELs"
Robert Grubbs, California Inst. of Technology
"The Use of Ruthenium Carbenes in Synthesis"
Friday noon conference adjournment
Return to top
|